Cargando…

The Use of Pharmacogenomics for Selection of Therapy in Non-Small-Cell Lung Cancer

INTRODUCTION: Performance status (PS) is the only known clinical predictor of outcome in patients with advanced non-small-cell lung cancer (NSCLC), although pharmacogenomic markers may also correlate with outcome. The aim of our study was to correlate clinical and pharmacogenomic measures with overa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Nagla A, Bui, Hai, Pathrose, Peterson, Starnes, Sandra, Patil, Ninad, Shehata, Mahmoud, Mostafa, Ahmed, Rao, MB, Zarzour, Ahmad, Anderson, Marshall
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259862/ https://www.ncbi.nlm.nih.gov/pubmed/25520568 http://dx.doi.org/10.4137/CMO.S18369

Ejemplares similares

Does Molecular Profiling of KRAS-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?
por: Karim, Nagla Abdel, et al.
Publicado: (2022)

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
por: Karim, Nagla Abdel, et al.
Publicado: (2014)

Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model
por: Vasiliauskas, Juozas, et al.
Publicado: (2014)

Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?
por: Karim, Nagla Abdel, et al.
Publicado: (2020)

Influenza Vaccination in Cancer Patients Undergoing Systemic Therapy
por: Shehata, Mahmoud A, et al.
Publicado: (2014)

Benign Metastasizing Leiomyoma: A Rare Type of Lung Metastases—Two Case Reports and Review of the Literature
por: Taftaf, Rokana, et al.
Publicado: (2014)

Pharmacogenomics in Palliative Medicine
por: Rao, Mahadev
Publicado: (2019)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Assessment of Tissue Adequacy by EBUS in Conjunction with PET Scan and Operator’s Experience
por: Karim, Nagla Abdel, et al.
Publicado: (2022)

HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses
por: Benight, Nancy M., et al.
Publicado: (2015)

Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Papillary renal cell carcinoma: what is missing in research? A case report and a review of literature
por: Eldessouki, Ihab, et al.
Publicado: (2019)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
por: Caputo, Valerio, et al.
Publicado: (2021)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Consistent terminology for medication-related problems in pharmacogenomic cases
por: Polasek, Thomas M., et al.
Publicado: (2023)

Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies
por: Rao, J. Sunil, et al.
Publicado: (2017)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2017)

Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer
por: Wildey, Gary, et al.
Publicado: (2014)

Analytical strategies for discovery and replication of genetic effects in pharmacogenomic studies
por: Kohler, Jared R, et al.
Publicado: (2014)

Bilateral Choroidal Metastasis from Non-Small Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2014)

Pharmacogenomics: methods and protocols
por: Lai, C
Publicado: (2006)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)

Pharmacogenomics of cardiovascular drugs
por: Adithan, C
Publicado: (2014)

Chapter 7: Pharmacogenomics
por: Karczewski, Konrad J., et al.
Publicado: (2012)

Web Resources for Pharmacogenomics
por: Zhang, Guoqing, et al.
Publicado: (2015)

Assessment of pharmacogenomic agreement
por: Safikhani, Zhaleh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fnp487r29uvhckj36rkcmk3jot